Matthew Pierre Deek, Xiaolei Shi, Noura Radwan, Caitlin Eggleston, Kaysee Baker, Zaker Hamid Rana, Matthew J. Ferris, Young Kwok, Soren Bentzen, Ronald D Ennis, Lara Hathout, Biren Saraiya, Tina M. Mayer, Heather Dorothy Mannuel, Arif Hussain, Matthew Abramowitz, Alejandro Berlin, Mark V. Mishra, Phuoc T. Tran, Jason K. Molitoris. "Phase 2 randomized study of high-risk metachronous oligometastatic prostate cancer with high-risk mutations treated with metastasis-directed therapy and niraparib/abiraterone acetate plus prednisone (KNIGHTS) trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps283